A recent Fifth Circuit decision threatens to reinstate unnecessary, medically unjustified barriers to mifepristone, forcing patients to travel long distances for care that has been safely delivered via telemedicine and pharmacies for years.

As physicians, we know this ruling puts patients at risk, delays time-sensitive care, and undermines evidence-based medicine.

We are calling on the U.S. Supreme Court to act decisively and permanently restore access to mifepristone.

Add your name to stand with physicians across the country in defending patient access, protecting clinical decision-making, and ensuring that health care remains guided by science, not politics.